CME Group Inc. (NASDAQ:CME) Holdings Cut by Bank of New York Mellon Corp

Bank of New York Mellon Corp lowered its position in CME Group Inc. (NASDAQ:CME - Free Report) by 3.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,176,107 shares of the financial services provider's stock after selling 196,174 shares during the quarter. Bank of New York Mellon Corp owned 1.71% of CME Group worth $1,638,459,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. SeaCrest Wealth Management LLC boosted its stake in shares of CME Group by 3.0% during the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after acquiring an additional 40 shares during the last quarter. New Age Alpha Advisors LLC boosted its stake in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Wealthcare Advisory Partners LLC grew its holdings in shares of CME Group by 3.6% during the first quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock worth $356,000 after buying an additional 47 shares in the last quarter. Koshinski Asset Management Inc. raised its position in shares of CME Group by 1.4% in the first quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock valued at $934,000 after buying an additional 48 shares during the last quarter. Finally, Berry Wealth Group LP raised its position in shares of CME Group by 0.4% in the first quarter. Berry Wealth Group LP now owns 13,561 shares of the financial services provider's stock valued at $3,598,000 after buying an additional 49 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Stock Down 0.4%

Shares of CME stock traded down $1.00 during trading hours on Friday, reaching $274.83. The company had a trading volume of 1,234,017 shares, compared to its average volume of 2,189,328. The stock's fifty day simple moving average is $276.40 and its 200 day simple moving average is $257.89. The company has a market capitalization of $99.04 billion, a P/E ratio of 27.65, a price-to-earnings-growth ratio of 3.75 and a beta of 0.44. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a twelve month low of $193.17 and a twelve month high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the company earned $2.50 earnings per share. CME Group's revenue for the quarter was up 10.4% on a year-over-year basis. As a group, sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were given a $1.25 dividend. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. CME Group's payout ratio is currently 50.30%.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Citigroup lifted their price objective on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday. Royal Bank Of Canada reiterated a "sector perform" rating and issued a $269.00 target price on shares of CME Group in a research note on Thursday, April 3rd. UBS Group lifted their price target on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a report on Friday, April 25th. Finally, Barclays raised their target price on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $259.87.

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 390 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total value of $108,225.00. Following the completion of the transaction, the general counsel owned 6,708 shares of the company's stock, valued at approximately $1,861,470. This represents a 5.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Daniel G. Kaye sold 500 shares of the stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the transaction, the director owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.